Bhat et al., 2023 - Google Patents
Preliminary Evaluation of Lablab purpureus Phytochemicals for Anti-BoHV-1 Activity Using In Vitro and In Silico ApproachesBhat et al., 2023
View HTML- Document ID
- 7161013649675576539
- Author
- Bhat S
- Pradeep S
- Patil S
- Flores-Holguín N
- Glossman-Mitnik D
- Frau J
- Sommano S
- Ali N
- Mohany M
- Shivamallu C
- Prasad S
- Kollur S
- Publication year
- Publication venue
- ACS omega
External Links
Snippet
Lablab purpureus from the Fabaceae family has been reported to have antiviral properties and used in traditional medical systems like ayurveda and Chinese medicine and has been employed to treat a variety of illnesses including cholera, food poisoning, diarrhea, and …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rauf et al. | COVID-19 pandemic: epidemiology, etiology, conventional and non-conventional therapies | |
| Vellingiri et al. | COVID-19: A promising cure for the global panic | |
| Choi et al. | Aloe vera and its components inhibit influenza A virus-induced autophagy and replication | |
| Subbaiyan et al. | In silico Molecular Docking Analysis Targeting SARSCoV-2 Spike Protein and Selected Herbal Constituents. | |
| Al-Sanea et al. | Strawberry and ginger silver nanoparticles as potential inhibitors for SARS-CoV-2 assisted by in silico modeling and metabolic profiling | |
| Adiguna et al. | Antiviral activities of andrographolide and its derivatives: mechanism of action and delivery system | |
| Khan et al. | Discovery of potential inhibitors of the receptor-binding domain (RBD) of pandemic disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala through molecular docking | |
| CN103599071B (en) | A kind of preparation method of polyinosinic-polycytacidic acidic dry powder | |
| Farooq et al. | Natural and synthetic drugs as potential treatment for coronavirus disease 2019 (COVID-2019) | |
| Ho et al. | Characterization of the anti-influenza activity of the Chinese herbal plant Paeonia lactiflora | |
| Dutta et al. | Appraisals of the Bangladeshi medicinal plant Calotropis gigantea used by folk medicine practitioners in the management of COVID-19: a biochemical and computational approach | |
| CN103908473B (en) | Treat and prevent the application of the nanometer silver anti-cancer composition of uterus neck cancer | |
| Xiang et al. | Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies | |
| Singh et al. | Exploring the therapeutic potential of marine-derived bioactive compounds against COVID-19 | |
| Bhat et al. | Preliminary Evaluation of Lablab purpureus Phytochemicals for Anti-BoHV-1 Activity Using In Vitro and In Silico Approaches | |
| Prabhu et al. | Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review | |
| Devendra et al. | A review on the COVID-19, its history, diagnostic approaches, role of herbs and current world scenario | |
| Ozeer et al. | A comprehensive review of phytochemicals of Withania somnifera (L.) Dunal (Solanaceae) as antiviral therapeutics | |
| Ramli et al. | Phytochemicals of withania somnifera as a future promising drug against SARS-CoV-2: pharmacological role, molecular mechanism, molecular docking evaluation, and efficient delivery | |
| Uhomoibhi et al. | Molecular modeling identification of potential drug candidates from selected African plants against SARS-CoV-2 key druggable proteins | |
| Elkhatib et al. | Narrative review on century of respiratory pandemics from Spanish flu to COVID-19 and impact of nanotechnology on COVID-19 diagnosis and immune system boosting | |
| Shanmugam et al. | SARS-CoV-2/COVID-19 pandemic-an update | |
| Tungadi et al. | COVID-19: clinical characteristics and molecular levels of candidate compounds of prospective herbal and modern drugs in Indonesia | |
| Al-Kuraishy et al. | Monkeypox epidemic at the door: should we remain idly by or prepare strongly? | |
| Lin et al. | Antiviral and Immunomodulatory Activities of Clinacanthus nutans (Burm. f.) Lindau |